Date Time
Share
SpeeDx and MolGen announce partnership for COVID-19 test solution Australian company SpeeDx and MolGen have announced an agreement
Australian company SpeeDx and MolGen have announced an agreement to collaborate on the supply and distribution of clinical diagnostics products and instrumentation across Europe and the Asia Pacific.
Founded in 2009, SpeeDx is an Australian-based private company with subsidiary offices in Austin, Texas and London, with distributors across Europe. SpeeDx specialises in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management
The new partnership with MolGen links specimen handling, nucleic acid extraction, assay set-up, amplification, and results reporting in a seamless integration of the companies’ technologies.
SpeeDx Pty, Ltd : SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
The Premier, Minister for Jobs, Investment, Tourism and Western Sydney
Medical technology is the star of the NSW Government’s first round of the Jobs Plus Program delivering about 280 jobs with Baxter Healthcare and biotechnology company SpeeDx announced as the first businesses to be part of the program.
Premier Gladys Berejiklian said the $250 million program from Investment NSW was an opportunity for the state to invest in its future prosperity by nurturing industries, technology and stimulating job creation.
“NSW is open for business – our world-leading management of the pandemic has made our state a premier destination for relocation and expansion,” Ms Berejiklian said.